JPS6120274B2 - - Google Patents
Info
- Publication number
- JPS6120274B2 JPS6120274B2 JP11599078A JP11599078A JPS6120274B2 JP S6120274 B2 JPS6120274 B2 JP S6120274B2 JP 11599078 A JP11599078 A JP 11599078A JP 11599078 A JP11599078 A JP 11599078A JP S6120274 B2 JPS6120274 B2 JP S6120274B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- keto
- acid
- cooh
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000004716 alpha keto acids Chemical class 0.000 claims description 19
- 230000001580 bacterial effect Effects 0.000 claims description 13
- 244000005700 microbiome Species 0.000 claims description 13
- 102000016938 Catalase Human genes 0.000 claims description 9
- 108010053835 Catalase Proteins 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- 241001480014 Trigonopsis Species 0.000 claims description 5
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 5
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims description 2
- 150000001371 alpha-amino acids Chemical class 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 150000004715 keto acids Chemical class 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- WVVOBOZHTQJXPB-UHFFFAOYSA-N N-anilino-N-nitronitramide Chemical compound [N+](=O)([O-])N(NC1=CC=CC=C1)[N+](=O)[O-] WVVOBOZHTQJXPB-UHFFFAOYSA-N 0.000 description 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 description 3
- 229930182819 D-leucine Natural products 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- RSTKLPZEZYGQPY-UHFFFAOYSA-N 3-(indol-3-yl)pyruvic acid Chemical compound C1=CC=C2C(CC(=O)C(=O)O)=CNC2=C1 RSTKLPZEZYGQPY-UHFFFAOYSA-N 0.000 description 2
- BKAJNAXTPSGJCU-UHFFFAOYSA-N 4-methyl-2-oxopentanoic acid Chemical compound CC(C)CC(=O)C(O)=O BKAJNAXTPSGJCU-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000589232 Gluconobacter oxydans Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 150000007649 L alpha amino acids Chemical class 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 241000588767 Proteus vulgaris Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241001480015 Trigonopsis variabilis Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000012531 culture fluid Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000004323 potassium nitrate Substances 0.000 description 2
- 235000010333 potassium nitrate Nutrition 0.000 description 2
- 229940007042 proteus vulgaris Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 229960000344 thiamine hydrochloride Drugs 0.000 description 2
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 2
- 239000011747 thiamine hydrochloride Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241001362614 Crassa Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AGPKZVBTJJNPAG-RFZPGFLSSA-N D-Isoleucine Chemical compound CC[C@@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-RFZPGFLSSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 1
- 229930195711 D-Serine Natural products 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 1
- 229930182847 D-glutamic acid Natural products 0.000 description 1
- HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 description 1
- 229930195721 D-histidine Natural products 0.000 description 1
- 229930182845 D-isoleucine Natural products 0.000 description 1
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 description 1
- 229930182818 D-methionine Natural products 0.000 description 1
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 description 1
- 229930182832 D-phenylalanine Natural products 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 description 1
- 229930182831 D-valine Natural products 0.000 description 1
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 241000221960 Neurospora Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940021745 d- arginine Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 1
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229950010030 dl-alanine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- -1 etc. Chemical compound 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- FGKJLKRYENPLQH-UHFFFAOYSA-N isocaproic acid Chemical compound CC(C)CCC(O)=O FGKJLKRYENPLQH-UHFFFAOYSA-N 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000005895 oxidative decarboxylation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- XZTJQQLJJCXOLP-UHFFFAOYSA-M sodium;decyl sulfate Chemical compound [Na+].CCCCCCCCCCOS([O-])(=O)=O XZTJQQLJJCXOLP-UHFFFAOYSA-M 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- WWJZWCUNLNYYAU-UHFFFAOYSA-N temephos Chemical compound C1=CC(OP(=S)(OC)OC)=CC=C1SC1=CC=C(OP(=S)(OC)OC)C=C1 WWJZWCUNLNYYAU-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は微生物酵素の作用を利用したα−ケト
酸の製造法に関する。
必須アミノ酸に対応するα−ケト酸は尿毒症な
どの腎臓の機能障害に対して有用な医薬品であ
る。
本発明者らはα−ケト酸の製造法について種々
検討した結果、一般式
〔式中、Rは−CH2R1又は
The present invention relates to a method for producing α-keto acids using the action of microbial enzymes. α-keto acids corresponding to essential amino acids are useful medicines for renal dysfunction such as uremia. As a result of various studies on the production method of α-keto acids, the present inventors found that the general formula [In the formula, R is -CH 2 R 1 or
【式】(ここで
R1は−H、−OH、−COOH、−CH2COOH、
[Formula] (where R 1 is -H, -OH, -COOH, -CH 2 COOH,
【式】−CH2SCH3、− CH2CH2CH2NH2、[Formula] −CH 2 SCH 3 , −CH 2 CH 2 CH 2 NH 2 ,
【式】【formula】
【式】であり、R2
は−CH3、C2H5である)を示す。〕
で表わされるα−アミノ酸のD−体又はその塩に
ドリゴノプシス属に属する微生物の培養物、菌体
もしくはそれらの処理物を必要に応じカタラーゼ
の存在下に作用させることにより、上記アミノ酸
が対応するα−ケト酸になること、又、上記アミ
ノ酸のラセミ体にトリゴノプシス属に属する微生
物の培養物、菌体もしくはそれらの処理物及びα
−アミノ酸のL−体又はその塩をα−ケト酸に変
換せしめる能力を有する微生物の培養物、菌体も
しくはそれらの処理物を必要に応じ、カタラーゼ
の存在下に作用させることにより、対応するα−
ケト酸になることを見出し本発明を完成した。
本発明で用いられる微生物としてはトリゴノプ
シス属に属し、上記アミノ酸を対応するα−ケト
酸にする能力を有するものであれば何れも用いう
るが、好適なものとしてはトリゴノプシス・バリ
アビリス(Trigonopusis variabilis)IFO・755
がある。
本発明で用いられる微生物を培養する培地とし
ては、炭素源、窒素源、無機物等をほどよく含有
する培地であれば天然、培地、合成培地のいずれ
でもよい。
炭素源としてはグルコース、フラクトース、シ
ユークロース、マルトース、ガラクトース、リボ
ース、糖密、澱粉加水分解物などの炭水化物、ノ
ルマルパラフイン、ケロセンなどの炭化水素、メ
タノール、エタノール、グリセリン、ソルビトー
ルのアルコール類、ピルピン酸、乳酸、酢酸など
の有機酸があげられる。窒素源としては、アンモ
ニア、塩化アンモニウム、燐酸アンモニウム、硫
酸アンモニウム、炭酸アンモニウム、酢酸アンモ
ニウム、硝酸アンモニウム、硝酸ナトリウムなど
の無機窒素化合物、各種アミノ酸、尿素、ペプト
ン、肉エキス、酵母エキス、コーンスチープリカ
ー、カゼイン、蛋白加水分解物、フイツシユミー
ルなどの窒素含有物があげられる。
無機物としては燐酸−カリ、燐酸二カリ、燐酸
一ナトリウム、燐酸二ナトリウムなどの燐酸塩、
マグネシウム、マンガンなどの硫酸塩、塩酸塩が
あげられる。
本発明で用いられる微生物の培養条件として
は、温度20〜40℃、PH中性付近の好気的条件下で
1〜5日間培養を行えばよい。
こうして得られた培養液、それより集菌した菌
体又はそれを活性化処理したものがα−ケト酸の
生成反応に使用される。ここでいう活性化処理と
は、菌体を物理的あるいは化学的に処理して得ら
れる無細胞抽出液、それから公知の方法で精製し
た酵素、又は、菌体をそのまま活性化処理して得
られる活性化菌体を指す。活性化の方法として
は、例えば超音波処理、フレンチプレス処理、−
10℃以下で凍結次いで融解する方法、エタノー
ル、n−ブタノール、ベンゼン、トルエン、アセ
トンなどの有機溶剤処理、セチルトリメチルアン
モニウムブロマイド、ナトリウムデスオキシコレ
ート、ナトリウムデシルサルフエート、ソルビタ
ンモノラウレート、ジギトニン、トライトン×
100などの界面活性剤処理、高浸透圧溶液処理な
どがある。これらのうち、操作的に容易で且つ酵
素活性を充分高めうるものは、凍結融解法及びト
ルエン処理法である。
本発明を実施する場合、使用菌の培養時にカタ
ラーゼも生成するので、原則としてそれを添加す
る必要はないが、カタラーゼ活性が不十分な場
合、及び菌体から分離された酵素を用いる場合な
どにはカタラーゼを添加する必要がある。
なお、カタラーゼを必要とするのは生成したα
−ケト酸の酸化的脱カルボキシ化を阻止するため
である。
本発明の反応は通常PH7〜9、温度28〜35℃で
3〜6時間で終了する。又、この反応は好気的条
件下で行なうのがよい。
培養液又は反応液中に蓄積した目的物は、強酸
性イオン交換樹脂を用いる方法及び不溶性塩を作
り沈澱せしめる方法を組み合せて容易に、これを
抽出、精製単離することができる。
又、本発明において、原料として前述のアミノ
酸のラセミ体を用いた場合には本発明のトリゴノ
プシス属に属する微生物の培養物、菌体もしくは
それらの処理物とともに公知のL−α−アミノ酸
をα−ケト酸にする能力を有する微生物の培養
物、菌体もしくはそれらの処理物を同時に存在さ
せて、前述の方法と同様に反応、精製、単離する
ことにより対応するα−ケト酸を得ることができ
る。この方法は原料のα−アミノ酸を光学分割す
る必要がないので工業的価値の非常に高いもので
ある。
L−α−アミノ酸をα−ケト酸にする能力を有
する微生物としては例えばプロテウス・ブルガリ
スハウザー株(Proteus vulgaris Hauser)
IFO・3851、サルシナ・ルテア(Sarcina、
lutea)IFO・3030、アセトバクター・サブオキ
シダンス(Acetobacter suboxydans)IFO・
3172、ノイロスポラ・クラツサ(Neurospora
crassa)などがあげられる。
次に実施例により本発明を具体的に説明する。
なお、α−ケト酸は次の方法で定量した。
0.2〜1.5μmolのケト酸を含む検液5mlに1ml
のジニトロフエニルヒドラジン試薬(500μmol
のジニトロフエニルヒドラジンを2N塩酸100mlに
溶解したもの)を加え、30℃で10分間放置し、次
に4mlの水と10mlの2.2N苛性ソーダを加え撹拌
後、420nmで吸光度を測定する。一方、検液の
かわりに5mlの水を用いて上記と同じ操作を行な
い、ジニトロフエニルヒドラジン由来の吸光度を
測る。いま検波の吸光度をA、1μmolのケト酸
による吸光度をk、検液中のα−ケト酸のμmol
数をx、ジニトロフエニルヒドラジン1μmolに
よる吸光度をdとすると、A=kx+d(5.0−
x)従つてα−ケト酸のμmol数xは
x=(A−5d)/(k−d)で表わされる。
実施例 1
トリゴノプシス・バリアビリスIFO・755株を
接種したグルコーズ2%、硝酸カリウム0.5%、
リン酸第1カリウム0.4%、硫酸マグネシウム0.4
%、塩化カルシウム0.05%、ビオチン0.000002
%、チアミン塩酸塩0.00001%、DL−アラニン
0.3%を含む培地(殺菌前PH6.0)100mlを500ml容
三角コルベンに仕込み、27℃で48時間振盪培養し
た。一方、グルコース2%、シユークロース2
%、コーンステイープリカー1%、硝酸カリウム
0.5%、リン酸第1カリウム0.4%、硫酸マグネシ
ウム0.4%、塩化カルシウム0.05%、ビチオン
0.00002%、チアミン塩酸塩0.00001%、DL−メ
チオン0.4%(殺菌前PH6.0)からある本培養倍地
100mlを500ml容三角フラスコに仕込んで殺菌し、
これに前記前培養液1mlを接種して27℃で72時間
振盪培養した。この様にして得られた培養液を遠
心分離して集菌し、その菌に1.5mlのトルエンを
加え、30℃で30分間振盪し、次いで2mlの水を加
えて更に1時間振盪した。遠心分離して処理菌体
を回収し、20mlの0.1molピロリン酸バツフアー
(PH8.1)に懸濁し、酵素溶液とした。この酵素溶
液にD−ロイシンを2%の濃度になるように加え
(400mg)、30℃で3時間振盪しながら好気的に反
応させると、転換率90%(生成したα−ケト酸の
モル数/仕込んだ原料のα−アミノ酸のモル数)
でα−ケト−γ−メチル吉草酸の生成を認めた。
次いで菌体を除去して反応を停止させ、反応液
を強酸性イオン交換樹脂(ダイヤイオンPK208
三菱化成工業(株)製)で処理して未反応のD−
ロイシンを吸着除去した後、活性炭(精製白鷺
、武田薬品製)で脱色後、水酸化カルシウムで
PH4.5に調整し、減圧濃縮して析出した白色結晶
を濾取した。得られた結晶の乾燥重量は260mg
(純度100%)、生成収率は81%(得られたα−ケ
ト酸のモル数/生成したα−ケト酸のモル数)で
あつた。
実施例 2
実施例1における、D−ロイシンの代りにD−
アルギニン、D−リジン、D−ヒスチジン、D−
グルタミン酸、D−アスパラギン酸、D−アラニ
ン、D−バリン、D−イソロイシン、D−セリ
ン、D−メチオニン、D−フエニルアラニン、D
−トリプトフアンを用いてそれぞれ実施例1と同
様な反応を行い、下表に示すように、おのおのに
対応するα−ケト酸を得た。[Formula] and R 2 is -CH 3 or C 2 H 5 ). ] By treating the D-isomer of the α-amino acid represented by or its salt with a culture, bacterial cells, or a processed product of a microorganism belonging to the genus Dorigonopsis in the presence of catalase as necessary, the above-mentioned amino acid is obtained. In addition, the racemic form of the above-mentioned amino acids may be added to cultures of microorganisms belonging to the genus Trigonopsis, bacterial cells or processed products thereof, and α-keto acids.
- If necessary, a culture of a microorganism, a bacterial cell, or a processed product thereof having the ability to convert the L-form of an amino acid or a salt thereof into an α-keto acid is allowed to act in the presence of catalase to convert the corresponding α −
They discovered that it becomes a keto acid and completed the present invention. As the microorganism used in the present invention, any microorganism belonging to the genus Trigonopsis can be used as long as it has the ability to convert the above-mentioned amino acids into the corresponding α-keto acids, but a preferred microorganism is Trigonopusis variabilis (IFO).・755
There is. The medium for culturing the microorganisms used in the present invention may be any natural medium, medium, or synthetic medium as long as it contains moderate amounts of carbon sources, nitrogen sources, inorganic substances, and the like. Carbon sources include carbohydrates such as glucose, fructose, sucrose, maltose, galactose, ribose, molasses, and starch hydrolysates, hydrocarbons such as normal paraffin and kerosene, alcohols such as methanol, ethanol, glycerin, and sorbitol, pyrupic acid, Examples include organic acids such as lactic acid and acetic acid. Nitrogen sources include inorganic nitrogen compounds such as ammonia, ammonium chloride, ammonium phosphate, ammonium sulfate, ammonium carbonate, ammonium acetate, ammonium nitrate, and sodium nitrate, various amino acids, urea, peptone, meat extract, yeast extract, corn steep liquor, casein, Examples include nitrogen-containing substances such as protein hydrolysates and fruit meal. Inorganic substances include phosphates such as potassium phosphate, dipotassium phosphate, monosodium phosphate, and disodium phosphate;
Examples include sulfates and hydrochlorides of magnesium and manganese. The microorganisms used in the present invention may be cultured for 1 to 5 days under aerobic conditions at a temperature of 20 to 40° C. and near neutral pH. The culture fluid thus obtained, the bacterial cells collected from the culture fluid, or those activated therefrom are used in the α-keto acid production reaction. The activation treatment here refers to a cell-free extract obtained by physically or chemically treating bacterial cells, an enzyme purified from the cell-free extract using a known method, or a cell-free extract obtained by activating bacterial cells as they are. Refers to activated bacterial cells. Examples of activation methods include ultrasonic treatment, French press treatment, -
Method of freezing and then thawing at 10℃ or below, treatment with organic solvents such as ethanol, n-butanol, benzene, toluene, acetone, etc., cetyltrimethylammonium bromide, sodium desoxycholate, sodium decyl sulfate, sorbitan monolaurate, digitonin, triton ×
There are surfactant treatments such as 100, high osmotic solution treatments, etc. Among these, the freeze-thaw method and the toluene treatment method are easy to operate and can sufficiently increase enzyme activity. When carrying out the present invention, catalase is also produced during the cultivation of the bacteria used, so in principle there is no need to add catalase. requires the addition of catalase. In addition, it is the generated α that requires catalase.
- To prevent oxidative decarboxylation of keto acids. The reaction of the present invention is usually completed in 3 to 6 hours at a pH of 7 to 9 and a temperature of 28 to 35°C. Moreover, this reaction is preferably carried out under aerobic conditions. The target product accumulated in the culture solution or reaction solution can be easily extracted, purified and isolated by a combination of a method using a strongly acidic ion exchange resin and a method of producing and precipitating an insoluble salt. In addition, in the present invention, when the racemic form of the amino acid described above is used as a raw material, known L-α-amino acids are mixed with α- The corresponding α-keto acid can be obtained by reacting, purifying, and isolating in the same manner as the above-mentioned method in the simultaneous presence of a culture, bacterial cells, or processed products of microorganisms that have the ability to produce a keto acid. can. This method has very high industrial value since it is not necessary to optically resolve the starting material α-amino acid. Examples of microorganisms that have the ability to convert L-α-amino acids into α-keto acids include Proteus vulgaris Hauser.
IFO・3851, Sarcina lutea (Sarcina,
lutea) IFO・3030, Acetobacter suboxydans (Acetobacter suboxydans) IFO・
3172, Neurospora cratusa
crassa), etc. Next, the present invention will be specifically explained with reference to Examples.
In addition, alpha-keto acid was quantified by the following method. 1ml for 5ml of test solution containing 0.2-1.5μmol of keto acid
dinitrophenylhydrazine reagent (500 μmol
dinitrophenylhydrazine dissolved in 100 ml of 2N hydrochloric acid) and left at 30°C for 10 minutes. Next, 4 ml of water and 10 ml of 2.2N caustic soda were added, stirred, and the absorbance was measured at 420 nm. On the other hand, the same operation as above is performed using 5 ml of water instead of the test solution, and the absorbance derived from dinitrophenylhydrazine is measured. Now, the absorbance of the detection is A, the absorbance due to 1 μmol of keto acid is k, and μmol of α-keto acid in the test solution.
If the number is x and the absorbance of 1 μmol of dinitrophenylhydrazine is d, then A=kx+d(5.0−
x) Therefore, the number x of μmol of α-keto acid is expressed as x=(A-5d)/(k-d). Example 1 Glucose 2%, potassium nitrate 0.5%, inoculated with Trigonopsis variabilis IFO 755 strain,
Potassium phosphate 0.4%, magnesium sulfate 0.4
%, calcium chloride 0.05%, biotin 0.000002
%, Thiamine Hydrochloride 0.00001%, DL-Alanine
100 ml of a medium containing 0.3% (PH 6.0 before sterilization) was placed in a 500 ml triangular Kolben, and cultured with shaking at 27°C for 48 hours. On the other hand, glucose 2%, sucrose 2%
%, cornstarch liquor 1%, potassium nitrate
0.5%, potassium phosphate 0.4%, magnesium sulfate 0.4%, calcium chloride 0.05%, bithion
Main culture medium consisting of 0.00002%, thiamine hydrochloride 0.00001%, DL-methion 0.4% (PH6.0 before sterilization)
Pour 100ml into a 500ml Erlenmeyer flask and sterilize it.
This was inoculated with 1 ml of the above preculture solution and cultured with shaking at 27°C for 72 hours. The culture solution thus obtained was centrifuged to collect the bacteria, 1.5 ml of toluene was added to the bacteria, and the mixture was shaken at 30°C for 30 minutes. Then, 2 ml of water was added and the mixture was further shaken for 1 hour. The treated bacterial cells were collected by centrifugation and suspended in 20 ml of 0.1 mol pyrophosphate buffer (PH8.1) to prepare an enzyme solution. D-leucine was added to this enzyme solution at a concentration of 2% (400 mg) and reacted aerobically with shaking at 30°C for 3 hours, resulting in a conversion rate of 90% (mol of α-keto acid produced). number/number of moles of α-amino acid in the raw material)
The formation of α-keto-γ-methylvaleric acid was observed. Next, the bacterial cells are removed to stop the reaction, and the reaction solution is treated with a strongly acidic ion exchange resin (Diaion PK208).
(manufactured by Mitsubishi Chemical Industries, Ltd.) and unreacted D-
After adsorbing and removing leucine, decolorizing with activated carbon (purified Shirasagi, Takeda Pharmaceutical Co., Ltd.), and then decolorizing with calcium hydroxide.
The pH was adjusted to 4.5, the mixture was concentrated under reduced pressure, and the precipitated white crystals were collected by filtration. The dry weight of the crystals obtained was 260 mg.
(purity 100%), and the production yield was 81% (number of moles of α-keto acid obtained/number of moles of α-keto acid produced). Example 2 In place of D-leucine in Example 1, D-
Arginine, D-lysine, D-histidine, D-
Glutamic acid, D-aspartic acid, D-alanine, D-valine, D-isoleucine, D-serine, D-methionine, D-phenylalanine, D
The same reaction as in Example 1 was carried out using -tryptophan, and the corresponding α-keto acids were obtained as shown in the table below.
【表】
オ酪酸
[Table] Obyric acid
【表】
率
フエニルアラ フエニルピルビン酸 88%
ニン
トリプトフア インドールピルビン酸 90%
ン
実施例 3
ペプトン1%、肉エキス1%、食塩0.5%を含
む培地(殺菌前PH7)を500ml容三角コルベンに
100ml仕込み、120℃で30分間滅菌処理をした後、
プロテウス・ブルガリスHauser株(I.F.
O.3851)を接種し、30℃で24時間振盪倍養し
た。こうして得た培養液に実施例1と同様の方法
で得たトリゴノプシス・バリアビリスIFO・755
株の活性化菌体懸濁液20ml(培養液100ml相当
分)及びDL−ロイシンを終濃度が2%になるよ
うに添し(2.4g)、30℃で3時間で好気的に振盪
しながら反応させると、転換率70%でα−ケト−
γ−メチル吉草酸の生成を認めた。
菌体を除去して反応を停止せしめ、反応液から
実施例1と同様の方法で目的物を単離した。得ら
れた白色結晶の乾燥重量は1.5g(純度100%)、
生成収率は80%であつた。
実施例 4
実施例1と同様の方法で得たトリゴノプシス・
バリアビリスIFO・755株の活性化菌体懸濁液20
mlにD−ロイシンを2%の濃度になるように加え
(400mg)更に9000uのカタラーゼを加えて、30℃
で3時間好気的に振盪しながら反応させると、転
換率95%でα−ケト−γ−メチル吉草酸を生成し
た。[Table] Percent phenylara phenylpyruvic acid 88%
Nintryptophore indolepyruvate 90%
Example 3 A medium containing 1% peptone, 1% meat extract, and 0.5% salt (PH7 before sterilization) was placed in a 500ml triangular container.
After preparing 100ml and sterilizing it at 120℃ for 30 minutes,
Proteus vulgaris Hauser strain (IF
O.3851) was inoculated and cultured with shaking at 30°C for 24 hours. Trigonopsis variabilis IFO 755 obtained in the same manner as in Example 1 was added to the thus obtained culture solution.
Add 20 ml of activated cell suspension of the strain (equivalent to 100 ml of culture solution) and DL-leucine to a final concentration of 2% (2.4 g), and shake aerobically at 30°C for 3 hours. When the reaction is carried out, α-keto-
Formation of γ-methylvaleric acid was observed. The bacterial cells were removed to stop the reaction, and the target product was isolated from the reaction solution in the same manner as in Example 1. The dry weight of the obtained white crystals was 1.5 g (100% purity).
The production yield was 80%. Example 4 Trigonopsis obtained in the same manner as in Example 1
Activated bacterial cell suspension of IFO 755 strain 20
Add D-leucine to a concentration of 2% (400 mg), add 9000 u of catalase, and incubate at 30°C.
When reacted for 3 hours with aerobic shaking, α-keto-γ-methylvaleric acid was produced at a conversion rate of 95%.
Claims (1)
【式】【式】−CH2SCH3、− CH2CH2CH2NH2、【式】 【式】【式】 であり、R2は−CH3、C2H5である)を示す。〕で
表わされるα−アミノ酸のD−体またはその塩に
トリゴノプシス属に属する微生物の培養物、菌体
もしくはそれらの処理物を必要に応じカタラーゼ
の存在下に作用させることを特徴とする一般式 R−COCOOH (式中Rは前記と同じ意味を表わす。) で表わされるα−ケト酸の製造法。 2 一般式 〔式中Rは−CH2R1または【式】(ここで R1は−H、−OH、−COOH、−CH2COOH、
【式】【式】−CH2SCH3、− CH2CH2CH2NH2、【式】 【式】【式】 であり、R2は−CH3、C2H5である。)を示す。〕
で表わされるα−アミノ酸のラセミ体又はその塩
に、トリゴノプシス属に属する微生物の培養物、
菌体もしくはそれらの処理物及びα−アミノ酸の
L−体又はその塩をα−ケト酸に変換せしめる能
力を有する微生物の培養物、菌体もしくはそれら
の処理物を必要に応じ、カタラーゼの存在下に作
用させることを特徴とする一般式 R−COCOOH (式中Rは前記と同じ意味を表わす。) で表わされるα−ケト酸の製造法。[Claims] 1. General formula [In the formula, R is -CH 2 R 1 or [Formula] (where R 1 is -H, -OH, -COOH, -CH 2 COOH,
[Formula] [Formula] -CH 2 SCH 3 , - CH 2 CH 2 CH 2 NH 2 , [Formula] [Formula] [Formula] and R 2 is -CH 3 , C 2 H 5 ) . ] The general formula R is characterized in that the D-form of the α-amino acid represented by the formula R or a salt thereof is treated with a culture of a microorganism belonging to the genus Trigonopsis, cells, or a treated product thereof in the presence of catalase if necessary. -COCOOH (In the formula, R has the same meaning as above.) A method for producing an α-keto acid represented by the formula: -COCOOH. 2 General formula [In the formula, R is -CH 2 R 1 or [Formula] (where R 1 is -H, -OH, -COOH, -CH 2 COOH,
[Formula] [Formula] -CH 2 SCH 3 , -CH 2 CH 2 CH 2 NH 2 , [Formula] [Formula] [Formula], and R 2 is -CH 3 and C 2 H 5 . ) is shown. ]
A culture of a microorganism belonging to the genus Trigonopsis,
Bacterial cells or their processed products and cultures of microorganisms capable of converting L-forms of α-amino acids or salts thereof into α-keto acids, microbial cells or their processed products, as necessary, in the presence of catalase. 1. A method for producing an α-keto acid represented by the general formula R-COCOOH (wherein R has the same meaning as above).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11599078A JPS5542550A (en) | 1978-09-22 | 1978-09-22 | Production of alpha-ketoacid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11599078A JPS5542550A (en) | 1978-09-22 | 1978-09-22 | Production of alpha-ketoacid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5542550A JPS5542550A (en) | 1980-03-25 |
| JPS6120274B2 true JPS6120274B2 (en) | 1986-05-21 |
Family
ID=14676125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11599078A Granted JPS5542550A (en) | 1978-09-22 | 1978-09-22 | Production of alpha-ketoacid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5542550A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7900826L (en) * | 1979-03-27 | 1980-09-28 | Brodelius P | USE OF IMMOBILIZED MICROBIAL ENZYM / CELL SYSTEMS FOR PREPARING ALFA KETOS ACIDS FROM SIMILAR AMINOS ACIDS |
| FR2517914B1 (en) * | 1981-12-07 | 1986-02-07 | Labo Cent Telecommunicat | TELEVISION SIGNAL RETRANSMISSION EQUIPMENT ON COMMON CHANNEL, WITH AUTOMATIC IMAGE / SOUND CONTROL |
| CN102459621B (en) * | 2009-06-05 | 2015-01-28 | 赢创德固赛有限公司 | A method for the preparation of 2-keto carboxylic acid |
-
1978
- 1978-09-22 JP JP11599078A patent/JPS5542550A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5542550A (en) | 1980-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2676568B2 (en) | Method for producing R (-)-mandelic acid and its derivatives | |
| JP2003199595A (en) | Method for producing optically active mandelic acid derivative | |
| JPS6120274B2 (en) | ||
| JP4235985B2 (en) | Method for producing α-hydroxy acid using microorganism and novel microorganism | |
| JPH0739385A (en) | Method for producing L-3,4-dihydroxyphenylalanine | |
| JPS60180596A (en) | Production of l-alpha-amino acid | |
| JPWO1997032030A1 (en) | Method for producing alpha-hydroxy acid using microorganisms and novel microorganisms | |
| US3957579A (en) | Method for preparing d-tartaric acid | |
| JPH01320991A (en) | Production of d-homophenylalanines | |
| JP2004254690A (en) | Method of producing dl-methionine | |
| JP2899071B2 (en) | Method for producing L-α-alanine | |
| WO1996031616A1 (en) | Process for producing l-2-aminoadipic acid | |
| JPS63157990A (en) | Method for producing L-α-methylphenylalanine | |
| JPH1042886A (en) | Method for producing β-alanine by microorganism | |
| JP2674076B2 (en) | Method for producing D-α-amino acid | |
| JP2002034584A (en) | METHOD FOR PRODUCING AMMONIUM SALT OF alpha-HYDROXYACID | |
| GB1577087A (en) | Enzyme preparation having l-amino acyl amidase activity | |
| JPWO2003062437A1 (en) | Method for producing α-hydroxy acid ammonium salt | |
| EP0315786A1 (en) | Process for the preparation of a d-alfa-amino acid from the corresponding alfa-keto acid | |
| JP2507465B2 (en) | Method for producing D-aspartic acid | |
| JPS6258710B2 (en) | ||
| JP2670130B2 (en) | Method for culturing Rhodococcus bacteria and method for producing 2-ketobutyric acid using the microorganism | |
| JPS5918994B2 (en) | Method for producing D-N-carbamyl (p-hydroxyphenyl) glycine | |
| JPS58175491A (en) | Preparation of l-phenylalanine | |
| JPS6219093A (en) | Production of l-phenylalanine |